Intracellular pH dynamics and charge-changing somatic mutations in cancer
- 13 April 2019
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 38 (1-2) , 17-24
Abstract
An unresolved question critical for understanding cancer is how recurring somatic mutations are retained and how selective pressures drive retention. Increased intracellular pH (pHi) is common to most cancers and is an early event in cancer development. Recent work shows that recurrent somatic mutations can confer an adaptive gain in pH sensing to mutant proteins, enhancing tumorigenic phenotypes specifically at the increased pHi of cancer. Newly identified amino acid mutation signatures in cancer suggest charge-changing mutations define and shape the mutational landscape of cancer. Taken together, these results support a new perspective on the functional significance of somatic mutations in cancer. In this review, we explore existing data and new directions for better understanding how changes in dynamic pH sensing by somatic mutation might be conferring a fitness advantage to the high pH of cancer.Keywords
This publication has 57 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Amino acid coevolution induces an evolutionary Stokes shiftProceedings of the National Academy of Sciences, 2012
- Clonal evolution in cancerNature, 2012
- Large shifts in pK a values of lysine residues buried inside a proteinProceedings of the National Academy of Sciences, 2011
- Signatures of mutation and selection in the cancer genomeNature, 2010
- A frequent kinase domain mutation that changes the interaction between PI3Kα and the membraneProceedings of the National Academy of Sciences, 2009
- Cofilin is a pH sensor for actin free barbed end formation: role of phosphoinositide bindingJournal of Cell Biology, 2008
- Structural model and functional significance of pH-dependent talin–actin binding for focal adhesion remodelingProceedings of the National Academy of Sciences, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor SensitivityCancer Cell, 2007